Sweeteners
fructose increases blood triglycerides
Leans support Sweeteners 🔬 Includes disconfirming
Part of: • fructose
RefutedContestedStrong support
consensus score 0.33
🧭 Read this score with how it was built in mindWe re-read the original papers and corrected what they actually say
Seven of the studies here were re-read against their own text and each had been recorded more strongly than it reads. The clearest: a 94-man randomised trial had been filed as showing fructose raises blood triglycerides, but the paper never measures blood triglycerides at all — it measures fat production in the liver, and reports no change in the triglyceride export that would follow. Once that and six others were corrected, what the library actually holds on this question is two human trials and nine animal studies, which is why the verdict fell. The direction may well be right; the evidence here is thinner than the old score implied.
📅 Last reviewed: 2026-07-15 ⓘ
Evidence ladder
How far up the ladder this claim has climbed. A high consensus on a low rung means "consistent so far," not "proven in people."
Top evidence so far: Human trials (RCT / n-of-1)
MechanismIn-vitroAnimalObservationalRCTMeta-analysis
How the studies fall
5 support 2 contradict 1 tested null 2 mixed · 10 sources, 7 independent groups
What the evidence shows
One of fructose's best-established distinctive harms: because the liver metabolizes fructose largely to fat, fructose-sweetened (and sucrose-sweetened, but not glucose-sweetened) drinks drive hepatic de novo lipogenesis and raise blood triglycerides — shown in controlled human trials even without excess calories. This is a genuine metabolic difference from glucose, not a myth.
The evidence (15)
| Source | Grade | Stance | Quality | Finding |
|---|---|---|---|---|
| Fauste E, Pérez-Armas M, Donis C, Otero P, Panadero MI, Bocos C 2025 · Mol Med | animal | mixed | moderate | Male rats born to mothers given 10% fructose water during pregnancy, or to control mothers, drank 10% fructose or 10% tagatose water for 21 days as adults (7-8 litters per group). Fructose raised plasma triglycerides only in the offspring of fructose-fed mothers; in offspring of control mothers triglyceridemia did not change, even though fructose supplied about 45% of their calories. Fructose's effect tracked hepatic fat synthesis (raised Scd1 in both maternal groups), while tagatose raised triglycerides in the programmed offspring by a separate intestinal bile-acid route. |
| Jensen T, Abdelmalek MF, Sullivan S, Nadeau KJ, Green M, Roncal C, Nakagawa T, Kuwabara M, Sato Y, Kang DH, Tolan DR, Sanchez-Lozada LG, Rosen HR, Lanaspa MA, Diehl AM, Johnson RJ 2018 · J Hepatol 2018 May;68(5):1063-1075 | observational | supports | low | Narrative review - no new data, zero-weight per the review-is-not-evidence rule. What it actually synthesizes is HEPATIC fat, not circulating triglycerides: 'Herein, we review the experimental and clinical evidence that fructose precipitates fat accumulation in the liver, due to both increased lipogenesis and impaired fat oxidation.' The mediator it advances is the authors' own fructokinase-C / uric-acid hypothesis: 'Recent evidence suggests that the predisposition to fatty liver is linked to the metabolism of fructose by fructokinase C, which results in ATP consumption, nucleotide turnover and uric acid generation that mediate fat accumulation.' No plasma or serum triglyceride result appears anywhere in the available text, so the claim's measured_by (blood triglycerides) is not reported here; the support is for the claim's stated hepatic de-novo-lipogenesis route only. The review's own clinical verdict is hedged: 'Early clinical studies suggest that reducing sugary beverages and total fructose intake, especially from added sugars, may have a significant benefit on reducing hepatic fat accumulation.' and 'We suggest larger, more definitive trials to determine if lowering sugar/HFCS intake, and/or blocking uric acid generation, may help reduce NAFLD and its downstream complications of cirrhosis and chronic liver disease.' Senior authorship is the Colorado fructose-uric-acid network (Johnson RJ, Lanaspa MA, Sanchez-Lozada, Nakagawa), which is advocating its own hypothesis here - hence quality: low rather than moderate. Abstract-only: J Hepatol full text not obtainable (Europe PMC returned 0 bytes for PMC5893377; local fulltext-cache entry is a 404 stub). |
| Kapiller M, Marcello GM, Hazai D, Andrásovszky E, Sótonyi P, Szabó J, Rácz B 2026 · Brain Structure & Function | animal | contradicts | moderate | Adult male Wistar rats (7-8 per group) ate isocaloric AIN-93G diets for four weeks in which 65% of the diet was fructose, glucose, or corn starch. Serum triglycerides did not differ between groups: fructose 1.91 ± 0.56 mmol/L, starch 1.39 ± 0.83, glucose 1.44 ± 0.58 (fructose vs starch p = 0.167, Bonferroni-adjusted 0.501). Cholesterol, insulin, leptin and glucagon were likewise unchanged; the only significant serum shift was lower fructosamine on fructose. The rats were few and how much each ate was not recorded, so a small triglyceride rise could have been missed. |
| Stanhope KL, Schwarz JM, Keim NL, Griffen SC, Bremer AA, Graham JL, Hatcher B, Cox CL, Dyachenko A, Zhang W, McGahan JP, Seibert A, Krauss RM, Chiu S, Schaefer EJ, Ai M, Otokozawa S, Nakajima K, Nakano T, Beysen C, Hellerstein MK, Berglund L, Havel PJ 2009 · J Clin Invest 2009 May;119(5):1322-1334 | RCT | supports | high | RCT/controlled feeding, 10 wk at 25% of energy: 'Fasting plasma triglyceride concentrations increased by approximately 10% during 10 weeks of glucose consumption but not after fructose consumption. In contrast, hepatic de novo lipogenesis (DNL) and the 23-hour postprandial triglyceride AUC were increased specifically during fructose consumption.' Supports the claim as scoped (DNL / postprandial TG); note the fasting-TG rise was in the glucose arm. |
| Pechanova O, Bulkova R, Vrankova S, Klimentova J, Galandakova Z, Cebova M 2025 · Physiol Res | animal | supports | moderate | Six rats per group drank 10% fructose water for 3 weeks. In spontaneously hypertensive rats plasma triglycerides rose from 0.686 to 1.626 mmol/L and VLDL from 0.277 to 0.740 mmol/L (both p<0.001), and total cholesterol from 1.507 to 1.741. In normotensive Wistar-Kyoto rats the triglyceride rise (1.252 to 1.603 mmol/L) was not statistically significant, and the only significant lipid change was a fall in HDL (1.616 to 1.522 mmol/L). Blood pressure did not change in either strain. |
| Geidl-Flueck B, Hochuli M, Németh Á, Eberl A, Derron N, Köfeler HC, Tappy L, Berneis K, Spinas GA, Gerber PA 2021 · J Hepatol | RCT | mixed | high | Double-blind randomised trial: 94 healthy men drank 80 g/day of fructose-, sucrose- or glucose-sweetened beverages, or none, for 7 weeks, with total energy intake similar across groups. Fructose and sucrose roughly doubled the liver's basal fatty-acid synthesis rate versus the no-beverage control (median 19.7 and 20.8 %/day vs 9.1; p = 0.013 and p = 0.0015); glucose did not (11.0, not significant). The paper reports no blood triglyceride level, and fructose did not change basal secretion of newly made VLDL-triglyceride, lipolysis or fat oxidation. |
| Pengnet S, Chonpathompikunlert P, Suttikul S, Lekchaoum T, Sitdhipol J, Tunsophon S, Malakul W 2026 · Probiotics Antimicrob Proteins | animal | supports | moderate | All the rats drank 20% fructose water for 12 weeks; what varied was the oral treatment - vehicle, the probiotic Bifidobacterium pseudolongum TISTR 2737 (2 x 10^8 CFU/rat), or metformin. Every comparison reported is against the fructose-fed vehicle group: the probiotic significantly lowered serum glucose, total cholesterol, triglycerides, LDL-C, uric acid and endothelin-1, and raised HDL-C and aortic nitric oxide. The report gives no numerical values and no comparison of fructose-fed against fructose-free animals, so it does not measure what fructose itself does to blood triglycerides. |
| Jung S, Bae H, Song WS, Jang C 2022 · Annu Rev Nutr | observational | supports | moderate | Narrative review (Annu Rev Nutr), abstract only — no full text obtainable. The abstract states the review covers 'the history of fructose consumption, biochemical and molecular pathways involved in fructose metabolism in different organs and gut microbiota, the role of fructose in the pathogenesis of metabolic diseases' and that rising fructose intake 'coincides with the exponential rise of metabolic diseases, including obesity, nonalcoholic fatty liver disease, cardiovascular disease, and diabetes.' It names no triglyceride or dyslipidemia finding in the readable text; reports no new data. Zero-weighted as evidence_role: review. |
| S'hih Y, Hinad I, Mrabet L, Bouasria H, Grina F, Koirala N, Loukili A, Ouahidi ML 2026 · J Mol Histol | animal | supports | low | Twelve Wistar rats, six per group, drank fructose water at rising strength - 20% in weeks 1-4, 25% in weeks 5-8, 30% in weeks 9-12 - while controls drank plain water. After 12 weeks the fructose group showed 'a very significant increase of total cholesterol and triglycerides levels in blood', plus higher body weight, higher fasting glucose and glucose intolerance. The report gives no numerical lipid values. Fructose was added on top of the diet with no glucose and no equal-calorie control, so the lipid rise cannot be separated from the extra calories and weight gained. |
| Essa HA, ElMosbah DE, Fahmy HA 2026 · PLOS One | animal | supports | moderate | In 24 male Sprague-Dawley rats randomly assigned to four groups of six, 20% (w/v) fructose in the drinking water for six weeks raised serum triglycerides nearly four-fold versus normal controls (302.8 +/- 2.84 vs 78.6 +/- 1.31 mg/dL, p <= 0.05), alongside total cholesterol 200.9 vs 68.9, LDL-C 106.4 vs 17.2 and fasting glucose 231.7 vs 74.4 mg/dL, and HDL-C falling to 25.9 from 42.6. Lemon and guava-lemon leaf extract (200 mg/kg/day) held triglycerides to 136.1 and 106.7 mg/dL. |
| Celik NC, Goc RY, Bahcecioglu IH, Ozercan IH, Tuzcu M, Ilhan N, Sahin K 2025 · Hepatol Forum | animal | supports | low | Male Sprague-Dawley rats (7 per group) given 50% fructose in drinking water for 8 weeks had serum triglycerides of 180±41 versus 120±6.8 in normal-diet controls, and cholesterol 68.4 versus 53, both significant at p<0.05, alongside higher liver weight, ALT, ALP, GGT and uric acid and histological steatohepatitis; fasting glucose did not differ between any groups. Adding the antibiotic rifaximin to the fructose diet moved triglycerides back toward control (150 once weekly, 130 three times weekly). The authors state they compared these six separate groups with a paired t-test. |
| Oyabambi AO, Agbaraolorunpo FM, Oguntebi EE, Oyakojo BC, Abena E 2026 · Current Research in Physiology | animal | supports | low | Thirty female Wistar rats, half of them pregnant, five per group, drank 10% fructose water for three weeks. Fructose significantly raised triglycerides, free fatty acids and cholesterol measured inside heart tissue, more so in the pregnant animals, and plasma cholesterol rose too. Triglycerides in blood were never measured, so the paper says nothing about fructose and circulating triglycerides. Sodium acetate given alongside the fructose (200 mg/kg/day) held these lipids near control. No numerical values appear in the text; the results are shown only in figures. |
| Liu SH, Hung RW, Chang TY, Chiang MT 2025 · J Food Drug Anal | animal | contradicts | moderate | Plasma triglyceride was significantly LOWER on the 43.1% high-fructose diet than on normal chow - Table 4: N 112.5 +/- 18.3 vs HF 59.6 +/- 13.5 mg/dL (n = 8/group, 21 wk, letters a vs b, p<0.05). Authors: 'the HF group in this study paradoxically exhibited significantly lower plasma triglyceride levels than the N group', attributed to hepatic TG retention limiting VLDL-TG secretion. Blood total cholesterol (157.7 -> 324.5) and AGEs DID rise; hepatic TG also rose, but this claim's object is blood triglycerides. |
| Gutiérrez-Esparza G, Martínez-García M, González Salazar MDC, Amezcua-Guerra LM, Brianza-Padilla M, Ramírez-delReal T, Hernández-Lemus E 2025 · Nutrients | observational | tested-null | low | Cross-sectional machine-learning analysis of the Tlalpan 2020 Mexico City cohort (3,156 adults; 1,151 in clusters). No effect estimate for triglycerides is reported. Across three clusters that differ mainly in total energy (about 1,660, 2,400 and 3,540 kcal/day; energy-adjusted fructose did not differ, p >= 0.22), triglycerides were 160.6, 173.4 and 170.4 mg/dL (ANOVA p = 0.233): an underpowered trend toward the claim, not a null pointing away. The XGBoost SHAP ranking lists triglycerides among the features pushing classification toward intake above 25 g/day, consistent with the claim but without an estimate or interval. Diet self-reported; the authors call the findings hypothesis-generating. |
| Herman MA, Birnbaum MJ 2021 · Cell Metab | observational | supports | moderate | Review of fructose metabolism. It reports that high-fructose diets raise blood triglycerides in animals and humans within days, and more strongly than comparable amounts of starch or glucose, and traces this to fructose driving hepatic de novo lipogenesis. It cites a 10-week trial in overweight adults in which isocaloric fructose- and glucose-sweetened drinks at 25% of energy raised body weight alike, but only fructose raised de novo lipogenesis and produced atherogenic dyslipidemia. Being a review, it adds no measurements of its own. |
Disagree, or know a study we missed?
We grade by evidence, not opinions. The way to weigh in is to point us to a study we haven't cited (check the evidence table above first), or to flag a problem with one we have. Every submission is reviewed; if it holds up, the grade updates and shows in Science Changes Its Mind.
Opens a short form. You'll sign in with Google so submissions are tied to a real account — we don't display your identity, and we only accept a link we can verify (PubMed, DOI, ClinicalTrials.gov).
Educational only, not medical advice. Grades and scores reflect published evidence weighted by study design and quality; see the methodology.